AIMS v. DEA

Federal legislators try again on psychedelics legislation; New Mexico to launch psilocybin program a year early; and Mapping psilocybin in…

Plus: Are the “MDMA blues” real? And newly launched Center for Psychedelic Policy

Dec 12, 2025 • jane c. hu

Psilocybin rescheduling petition now with Department of Health and Human Services; Did ancient peoples in Greece and India partake in…

Plus: Is Colorado’s next “natural medicine” ibogaine? And how important is the therapy part of psychedelic-therapy?

Aug 22, 2025 • jane c. hu

Federal court sides with DEA’s denial of access to psilocybin for terminally ill patients; COMPASS trigger law in Kansas; Could Arizona be…

Plus: UK considerations for psychedelic-assisted therapy, and reviewing heart risks of psychedelics

Feb 21, 2025 • jane c. hu

FDA will fast-track Lykos’s application for MDMA-assisted therapy for PTSD; New Illinois bill; and Canada’s first psilocybin clinical trial

Plus: Psychedelics as “synthetic surprise,” and new legal filing prods DEA for a ruling on psilocybin

Feb 16, 2024 • jane c. hu

Ninth Circuit Court of Appeals rules in favor of psilocybin rescheduling petition; Massachusetts ballot initiative advances; new psychedelic…

Plus: 2024 DEA quotas for research and including shamans in psychedelic science

Nov 3, 2023 • jane c. hu

Psilocybin sessions have begun in Oregon, DC-based PAC New Approach enters Massachusetts, and a tangle of patent claims

Plus: “Imprinting” in psychedelics, and the cancer patients v. DEA showdown continues

Jul 21, 2023 • jane c. hu

DEA charging thousands for Right To Try documents, a manifesto for psychonauts, and another one bites the dust

Plus: The State of Psychedelics and The Latest in Oregon

Sep 30, 2022 • jane c. hu

Psychedelic drugs for terminally ill patients, new federal bill includes additional psychedelics research funding, DEA faces FOIA suit

Plus: A poll of investors, and the Latest in Oregon

Jul 22, 2022 • jane c. hu

Microdosing might boost mood and mental health, preparing for off-label use of psychedelics, and terminally ill patients likely to take DEA…

Plus: Federal agencies weigh in on psychedelics and The State of Psychedelics

Jul 8, 2022 • jane c. hu

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts